【摘要】 目的 :探讨两种药物治疗方案对子宫肌瘤的经济效果。对象与方法 :经临床及B超检查诊断为子宫肌瘤的患者共 60例 ,随机分为两组。对照组 30例 ,使用布舍瑞林 ;治疗组 30例 ,使用米非司酮。应用药物经济学的成本 效果分析方法进行评价。结果 :治疗组的成本 /效果比显著低于对照组。结论 :米非司酮治疗的成本 效果较好。药物经济学在临床药物治疗中拟定出合理的成本 效果处方 ,为临床决策科学化提供了依据更多还原

【Abstract】 Objective: To explore the economic result of mifepristone vs buserelin in treatment of uterine leiomyoma. Object and Method: 60 patients, who were diagnosed as uterine leiomyoma, were randomly, meanly divided into treated group which were given mifepristone and controlled group which received buserelin, which were assessed by cost effectiveness analysis of pharmacoeconomics. Result: The ratio of cost effectiveness in treated group was significantly lower than in controlled group. Conclusion: The cost effectiveness is better with mifepristone in treatment of uterine leiomyoma to provide a foundation for clinical drug used to tend to rationalize.更多还原